Trial intelligence / Profile preview

Urinary Excretion of Acetylamantadine by Cancer Patients

NCT00755898Phase 2Completed

Sponsor
University of Manitoba
Start
Dec 2003
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of amantadine in cancer, sponsored by University of Manitoba. Started Dec 2003; status: completed.

02

Drugs

amantadine
03

Conditions

cancer

Beyond the preview

Go deeper on NCT00755898.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00755898.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call